- Home
- MIRM vs ROMA Comparison
MIRM vs ROMA Comparison
Compare MIRM & ROMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MIRM | ROMA |
|---|---|---|
| Founded | 2018 | 2018 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.7B | 134.6M |
| IPO Year | 2019 | 2022 |
Fundamental Metrics
Financial Performance| Metric | MIRM | ROMA |
|---|---|---|
| Price | $109.36 | $6.52 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 13 | 0 |
| Target Price | ★ $119.85 | N/A |
| AVG Volume (30 Days) | ★ 568.6K | 106.2K |
| Earning Date | 05-06-2026 | 12-23-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 74.59 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $19,138,000.00 | N/A |
| Revenue This Year | $26.22 | N/A |
| Revenue Next Year | $22.04 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $40.00 | $1.16 |
| 52 Week High | $110.49 | $11.77 |
Technical Indicators
Market Signals| Indicator | MIRM | ROMA |
|---|---|---|
| Relative Strength Index (RSI) | 73.13 | 56.46 |
| Support Level | $86.90 | $2.05 |
| Resistance Level | N/A | $8.73 |
| Average True Range (ATR) | 4.62 | 0.65 |
| MACD | 1.49 | 0.05 |
| Stochastic Oscillator | 92.53 | 73.61 |
Price Performance
Historical ComparisonAbout MIRM Mirum Pharmaceuticals Inc.
Mirum Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing therapies for rare and orphan diseases. Its main product, Livmarli (maralixibat), is an orally administered IBAT inhibitor approved to treat cholestatic pruritus in patients with Alagille syndrome. The company is also developing treatments such as maralixibat for PFIC and ALGS, and volixibat for adult cholestatic liver diseases. Mirum currently has three approved medicines: Livmarli, Cholbam, and Ctexli.
About ROMA Roma Green Finance Limited
Roma Green Finance Ltd is principally engaged in the provision of ESG, corporate governance and risk management as well as sustainability and climate change-related advisory services. The company works closely with its clients to help them understand, identify, manage, and overcome various business matters arising from such factors related to ESG, sustainability and climate change. Geographically, the company generates its revenue from Hong Kong and Singapore.